Skip to main content

Peer Review reports

From: Intranasal administration with recombinant vaccine PRVXJ-delgE/gI/TK-S induces strong intestinal mucosal immune responses against PDCoV

Original Submission
20 Apr 2023 Submitted Original manuscript
2 May 2023 Author responded Author comments - Ling Zhu
Resubmission - Version 2
2 May 2023 Submitted Manuscript version 2
3 May 2023 Author responded Author comments - Ling Zhu
Resubmission - Version 3
3 May 2023 Submitted Manuscript version 3
11 Jul 2023 Reviewed Reviewer Report - Muhammad Shahid Mahmood
13 Jul 2023 Reviewed Reviewer Report
31 Aug 2023 Author responded Author comments - Ling Zhu
Resubmission - Version 4
31 Aug 2023 Submitted Manuscript version 4
31 Aug 2023 Author responded Author comments - Ling Zhu
Resubmission - Version 5
31 Aug 2023 Submitted Manuscript version 5
13 Sep 2023 Reviewed Reviewer Report - Muhammad Shahid Mahmood
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
15 Sep 2023 Editorially accepted
23 Sep 2023 Article published 10.1186/s12917-023-03739-5

You can find further information about peer review here.

Back to article page